Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
Go back to Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 68.92 -0.15 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.07 | 52 Week High | $96.38 | |||
| Open | $70.24 | 52 Week Low | $47.92 | |||
| Day High | $70.27 | P/E | N/A | |||
| Day Low | $68.72 | EPS | $-0.42 | |||
| Volume | 6,157,716 | |||||
